The mechanistic target of rapamycin (mTOR) pathway integrates diverse environmental inputs, including immune signals and metabolic cues, to direct T-cell fate decisions 1 . The activation of mTOR, which is the catalytic subunit of the mTORC1 and mTORC2 complexes, delivers an obligatory signal for the proper activation and differentiation of effector CD4 1 T cells 2,3 , whereas in the regulatory T-cell (T reg ) compartment, the Akt-mTOR axis is widely acknowledged as a crucial negative regulator of T reg -cell de novo differentiation 4-8 and population expansion 9 . However, whether mTOR signalling affects the homeostasis and function of T reg cells remains largely unexplored. Here we show that mTORC1 signalling is a pivotal positive determinant of T reg -cell function in mice. T reg cells have elevated steady-state mTORC1 activity compared to naive T cells. Signals through the T-cell antigen receptor (TCR) and interleukin-2 (IL-2) provide major inputs for mTORC1 activation, which in turn programs the suppressive function of T reg cells. Disruption of mTORC1 through T reg -specific deletion of the essential component raptor leads to a profound loss of T regcell suppressive activity in vivo and the development of a fatal early onset inflammatory disorder. Mechanistically, raptor/mTORC1 signalling in T reg cells promotes cholesterol and lipid metabolism, with the mevalonate pathway particularly important for coordinating T regcell proliferation and upregulation of the suppressive molecules CTLA4 and ICOS to establish T reg -cell functional competency. By contrast, mTORC1 does not directly affect the expression of Foxp3 or anti-and pro-inflammatory cytokines in T reg cells, suggesting a nonconventional mechanism for T reg -cell functional regulation. Finally, we provide evidence that mTORC1 maintains T reg -cell function partly through inhibiting the mTORC2 pathway. Our results demonstrate that mTORC1 acts as a fundamental 'rheostat' in T reg cells to link immunological signals from TCR and IL-2 to lipogenic pathways and functional fitness, and highlight a central role of metabolic programming of T reg -cell suppressive activity in immune homeostasis and tolerance.
The mechanistic target of rapamycin (mTOR) pathway integrates diverse environmental inputs, including immune signals and metabolic cues, to direct T-cell fate decisions 1 . The activation of mTOR, which is the catalytic subunit of the mTORC1 and mTORC2 complexes, delivers an obligatory signal for the proper activation and differentiation of effector CD4 1 T cells 2, 3 , whereas in the regulatory T-cell (T reg ) compartment, the Akt-mTOR axis is widely acknowledged as a crucial negative regulator of T reg -cell de novo differentiation [4] [5] [6] [7] [8] and population expansion 9 . However, whether mTOR signalling affects the homeostasis and function of T reg cells remains largely unexplored. Here we show that mTORC1 signalling is a pivotal positive determinant of T reg -cell function in mice. T reg cells have elevated steady-state mTORC1 activity compared to naive T cells. Signals through the T-cell antigen receptor (TCR) and interleukin-2 (IL-2) provide major inputs for mTORC1 activation, which in turn programs the suppressive function of T reg cells. Disruption of mTORC1 through T reg -specific deletion of the essential component raptor leads to a profound loss of T regcell suppressive activity in vivo and the development of a fatal early onset inflammatory disorder. Mechanistically, raptor/mTORC1 signalling in T reg cells promotes cholesterol and lipid metabolism, with the mevalonate pathway particularly important for coordinating T regcell proliferation and upregulation of the suppressive molecules CTLA4 and ICOS to establish T reg -cell functional competency. By contrast, mTORC1 does not directly affect the expression of Foxp3 or anti-and pro-inflammatory cytokines in T reg cells, suggesting a nonconventional mechanism for T reg -cell functional regulation. Finally, we provide evidence that mTORC1 maintains T reg -cell function partly through inhibiting the mTORC2 pathway. Our results demonstrate that mTORC1 acts as a fundamental 'rheostat' in T reg cells to link immunological signals from TCR and IL-2 to lipogenic pathways and functional fitness, and highlight a central role of metabolic programming of T reg -cell suppressive activity in immune homeostasis and tolerance.
The evolutionarily conserved mTOR signalling pathway couples cell growth and proliferation to nutrient availability and metabolic cues 10 . To investigate the function of mTORC1 in naturally occurring T reg cells, we compared mTORC1 activity between T reg cells and naive T cells at steady state. T reg cells had relatively increased phosphorylation of S6 and 4E-BP1, two major mTORC1 downstream targets ( Fig. 1a and Supplementary Fig. 1a -c), whereas STAT5 phosphorylation was similar in both sets of cells ( Supplementary Fig. 1d ). This finding is consistent with a recent study describing elevated S6 phosphorylation in T reg cells compared with non-T reg cells 11 . T reg cells also contained a higher abundance of CD71 (the transferrin receptor) and, to a lesser extent, CD98 (a subunit of the L-amino acid transporter), key nutrient receptors that depend on mTORC1 activity for expression 12 (Fig. 1b ). Previous studies have demonstrated a requirement of mTORC1 for mitochondrial metabolism 13 , the dysregulation of which could affect the homeostasis of memory T cells 14 and haematopoietic stem cells 15 . T reg cells had reduced mitochondrial membrane potential, whereas their mitochondrial mass and reactive oxygen species (ROS) production were largely comparable to naive cells ( Supplementary Fig. 1e ). Thus, T reg cells exhibit distinct regulation of mTORC1 activity and metabolism under steady-state conditions. One of the hallmarks of T reg cells is that they are anergic in vitro on TCR stimulation alone 16 , but are highly proliferative in vivo 17, 18 . Whereas reversal of anergy has been suggested to impair T reg function 16 , T reg cells stimulated by TCR together with IL-2, or under lymphopenic conditions, possess enhanced suppressive activity 18, 19 . Indeed, prior stimulation of T reg cells with anti-CD3 upregulated their suppressive activity, and this was further enhanced by concomitant treatment with IL-2 ( Fig. 1c ). Such functional enhancements were associated with increased mTORC1 activity and expression of CTLA4 and ICOS, important effector molecules mediating T reg function 20, 21 (Fig. 1d ). Compared with IL-2, CD28-mediated co-stimulation had more modest enhancing effects on these events ( Supplementary Fig. 1f , g). Thus, TCR and IL-2 are the predominant signals that promote mTORC1 activity and the suppressive function of T reg cells.
Although these results indicate that mTORC1 is positively correlated with T reg suppressive activity, a number of recent studies have revealed a negative role of mTORC1 in T reg cells, including in the suppression of T reg differentiation 2,4-8 and population expansion 9 . To establish the physiological relevance of mTORC1 signalling in T reg cells, we deleted raptor, an obligatory component of the mTORC1 complex 10 , in T reg cells by crossing Rptor fl/fl mice with Foxp3 YFP-Cre mice 22 (designated Foxp3 cre Rptor fl/fl ). Raptor expression and S6 and 4E-BP1 phosphorylation were abolished in raptor-deficient T reg cells, but were normal in Foxp3 2 populations ( Supplementary Fig. 2a -c). Additionally, a slight increase of phosphorylation of Akt Ser 473 was observed in mutant T reg cells, whereas phosphorylation of Akt Thr 308 and Erk in T reg cells was not affected ( Supplementary Fig. 2d ). Thus, deletion of raptor specifically abrogated mTORC1 activity. Surprisingly, Foxp3 cre Rptor fl/fl mice developed profound inflammatory diseases, indicated by a reduced body size and hunched posture, crusting of ears, eyelids and tail, and skin ulceration particularly on the head and upper back ( Fig. 1e ). Foxp3 cre Rptor fl/fl mice showed extensive lymphadenopathy ( Supplementary Fig. 3a ) and infiltrations of lymphocytes and myeloid cells in colon mucosa, lung, liver sinusoids and skin ( Fig. 1f ), among other organs, before they died at a young age ( Supplementary Fig. 3b ). Foxp3 cre Rptor fl/fl mice had an increased CD8 1 -cell percentage and altered CD4 1 /CD8 1 ratio, highly elevated memory/effector phenotype (CD44 hi CD62L lo ) T cells, and expansion of CD11b 1 granulocytes and macrophages (Supplementary Fig. 3c-e ). Furthermore, T cells from Foxp3 cre Rptor fl/fl mice showed increased interferon (IFN)-c-, IL-4-and IL-17-producing CD4 1 cells and IFN-c-producing CD8 1 cells ( Fig. 1g ). These phenotypes are reminiscent of those observed in mice carrying the scurfy mutation 23 , indicating a loss of T reg function.
Despite developing severe autoimmune diseases, Foxp3 cre Rptor fl/fl mice had increased numbers of Foxp3 1 T reg cells ( Supplementary Fig. 4a ). Lineage-tracing experiments indicated that the increase of T reg cells was mainly ascribed to a more abundant population of canonical T reg cells, as indicated by concomitant expression of yellow fluorescent protein (YFP)tagged Foxp3 and specific Cre activity ( Fig. 2a ). Raptor-deficient T reg cells had normal Foxp3 expression and either increased or normal expression of many T reg signature molecules examined, whereas CD62L expression was reduced ( Supplementary Fig. 4b ). Thus, in settings of immune activation, raptor-deficient T reg cells acquired activated phenotypes. Additional analysis revealed highly reduced mitochondrial membrane potential and mass, and ROS production, in mutant T reg cells, whereas in vitro suppressive activity seemed to be largely undisturbed ( Supplementary Fig. 4b , c). To test the function of raptor-deficient T reg cells in vivo, we used a model of colitis induced by the transfer of pathogenic effector T cells (T eff ; CD4 1 CD45RB hi CD25 2 ) into Rag1 -/hosts, which could be prevented by cotransfer with wild-type T reg cells. However, cotransfer with raptordeficient T reg cells failed to inhibit colitis ( Fig. 2b ), or the expansion and IFN-c production of T eff cells ( Supplementary Fig. 4d ). Therefore, raptor is required for the suppressive function of T reg cells in vivo. 
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We speculated that the increased number and heightened activation phenotypes of T reg cells in Foxp3 cre Rptor fl/fl mice could be due to a compensatory response to the continuing inflammation 24 . To test this, we generated mixed bone marrow chimaeras by reconstituting sublethally irradiated Rag1 -/mice with bone marrow cells from CD45.1 1 mice mixed with those from either wild-type or Foxp3 cre Rptor fl/fl mice. Raptor-deficient T reg cells were underrepresented in the chimaeras (Fig. 2c) , with impaired expression of CTLA4 and ICOS but largely normal CD25 levels and mitochondrial parameters ( Fig. 2d ). These findings were recapitulated in 10-day-old Foxp3 cre Rptor fl/fl mice, which exhibited minimal immune activation ( Supplementary Fig. 4e ). Thus, in a disease-free environment, loss of raptor in T reg cells renders them at a competitive disadvantage and compromises the expression of CTLA4 and ICOS. By contrast, the pronounced mitochondrial defects in T reg cells from Foxp3 cre Rptor fl/fl mice ( Supplementary Fig. 4b) were not intrinsically due to raptor deficiency, but were probably a compensatory response, as observed in haematopoietic stem cells lacking the metabolic sensor LKB1 (ref. 15) .
To facilitate mechanistic studies of raptor-deficient T reg cells without the influence of continuing inflammation, we generated Cd4-Cre;Rptor fl/fl (Cd4 cre Rptor fl/fl ) mice, in which raptor was deleted in all ab T cells. Cd4 cre Rptor fl/fl mice showed a small reduction of T reg numbers in peripheral lymph nodes but not the spleen ( Supplementary  Fig. 5a ), and immunoblots confirmed the loss of S6 and 4E-BP1 phosphorylation in these T reg cells ( Supplementary Fig. 5b ). Expression of CTLA4, ICOS and CD71 was impaired in T reg cells from Cd4 cre Rptor fl/fl mice, whereas the levels of Foxp3, CD25 and other markers were normal ( Fig. 2e and Supplementary Fig. 5c ). In vitro assays revealed a loss of the suppressive activity of T reg cells from Cd4 cre Rptor fl/fl mice (Fig. 2f ). These T reg cells also exhibited severely impaired in vivo suppressive activity, because they failed to suppress colitis or IFN-c production mediated by T eff cells ( Fig. 2g and Supplementary Fig. 5d ). Analysis of mixed chimaeras composed of CD45.1 1 and Cd4 cre Rptor fl/fl cells confirmed that raptor-deficient T reg cells were reduced as a percentage of total CD4 1 T cells with impaired CTLA4 and ICOS expression ( Supplementary Fig. 5e ). Thus, T reg cells deficient in mTORC1 have an intrinsic defect in suppressive activity. Nonetheless, Cd4 cre Rptor fl/fl mice exhibited normal health status, which was probably due to impaired activation of conventional T cells (K.Y. and H.C., unpublished observations). We found a similar requirement of raptor in T reg suppressive activity after Cre-ER T2mediated acute deletion of raptor in adult mice ( Supplementary Fig. 6 ).
Cytokines produced by T reg cells represent an important immunosuppressive mechanism 25 . The anti-inflammatory cytokines TGF-b1 and IL-10 were expressed normally in raptor-deficient T reg cells (Supplementary Fig. 7a, b ). Although T reg cells from Foxp3 cre Rptor fl/fl mice expressed increased IFN-c, which may compromise T reg function 26 , T reg cells from Cd4 cre Rptor fl/fl did not (data not shown), thereby excluding such phenotypes as cell intrinsic. Moreover, ablation of IFN-c did not ameliorate the immune-activation phenotypes of Foxp3 cre Rptor fl/fl mice ( Supplementary Fig. 7c ). Thus, the severe autoimmune phenotypes of Foxp3 cre Rptor fl/fl mice probably occur independently of cytokine dysregulation.
We therefore focused on the effects of raptor on T reg surface effector molecules, especially CTLA4 and ICOS, which were greatly reduced in T reg cells from multiple raptor-deficient genetic models in an intrinsic manner (Fig. 2d, e and Supplementary Figs 4e, 5e ). Moreover, CTLA4 and, to a lesser extent, ICOS were further increased upon in vitro stimulation, and this upregulation correlated with T reg -cell proliferation. Such upregulation was blunted in T reg cells from Cd4 cre Rptor fl/fl mice, which was associated with impaired proliferation ( Fig. 3a and Supplementary Fig. 8a) . Moreover, when wild-type T reg cells were transferred into unmanipulated CD45.1 1 mice, a proportion of them divided and upregulated CTLA4 (Fig. 3b ). However, T reg cells from Cd4 cre Rptor fl/fl or Foxp3 cre Rptor fl/fl mice failed to proliferate or upregulate CTLA4 on transfer into CD45.1 1 mice ( Fig. 3b and Supplementary  Fig. 8b ). Markedly diminished homeostatic proliferation and CTLA4 upregulation were also observed when raptor-deficient T reg cells were transferred into Rag1 -/mice ( Supplementary Fig. 8c ). Altogether, loss of raptor inhibits T reg -cell proliferation in vitro and in vivo. Furthermore, 
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the proliferative defect was associated specifically with impaired CTLA4 and ICOS expression, whereas apoptosis or other activation-induced events such as upregulation of GATA3 and CD103 were independent of raptor (data not shown). Thus, mTORC1 is important for coordinating T reg -cell proliferation and CTLA4 and ICOS expression, which may collectively contribute to the T reg suppressive function.
To explore raptor/mTORC1-dependent molecular mechanisms, we used functional genomics and compared gene expression profiles of T reg cells from Cd4 cre Rptor fl/fl and wild-type mice. Gene-set enrichment analysis revealed that cholesterol biosynthesis was the most altered pathway in a raptor-dependent manner: expression of many genes in this pathway was downregulated after raptor deletion ( Fig. 3c and Supplementary Fig. 9a ), including those encoding 3-hydroxy-3methylglutaryl-CoA reductase (HMGCR), squalene epoxidase (SQLE) and isopentenyl-diphosphate delta isomerase 1 (IDI1), which was verified by real-time polymerase chain reaction (PCR) analysis (Fig. 3d ). Furthermore, on TCR stimulation, raptor-deficient T reg cells failed to synthesize lipids from glucose efficiently (Fig. 3e) , and had reduced cellular cholesterol (Fig. 3f) . These results establish a role of mTORC1 in promoting cholesterol/lipid biosynthesis. Given the interconnected relationship between the biosynthetic and bioenergetic programs 27 , we determined the role of mTORC1 in T reg bioenergetics by measuring the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR), which denoted glycolysis and mitochondrial respiration, respectively. Raptor-deficient T reg cells showed decreased ECAR and OCR ( Supplementary Fig. 9b, c) , indicating a requirement for mTORC1 in bioenergetics. We therefore determined the de novo lipid synthesis rate by measuring the incorporation of 14 C-acetate into cellular lipids, thereby bypassing the requirement of mTORC1 in glycolysis or mitochondrial activity. Indeed, raptor deficiency diminished the synthesis of lipids from 14 C-acetate in T reg cells ( Supplementary   Fig. 9d ). These results demonstrated a specific role of mTORC1 in orchestrating the lipogenic program.
To test the functional significance of lipid metabolism, we activated T reg cells in the presence of 25-hydroxycholesterol, and this general lipid synthesis inhibitor potently blocked T reg suppressive activity (Supplementary Fig. 10a ). Direct inhibition of HMGCR, the rate-limiting enzyme in the synthesis of cholesterol and isoprenoid lipids, by simvastatin also impaired T reg suppressive activity. Importantly, simvastatininduced inhibition was completely reversed by the simultaneous addition of mevalonate, the metabolite downstream of HMGCR (Fig. 3g) . Similar effects were observed after treatments with atorvastatin and lovastatin ( Supplementary Fig. 10b ). The inhibitory effects of these agents on T reg -cell function were associated with impaired T reg -cell proliferation and effector molecule upregulation ( Supplementary Fig. 10c ) in a mevalonate-dependent manner ( Supplementary Fig. 10d ). Furthermore, proliferation and CTLA4 and ICOS upregulation in T reg cells transferred into congenic CD45.1 1 mice were diminished by statin treatment in vivo ( Supplementary Fig. 11 ). Altogether, our results show that raptor/ mTORC1 signalling promotes the lipogenic program, with the mevalonate pathway particularly important for mediating T reg -cell proliferation, CTLA4 and ICOS upregulation, and functional fitness.
Moreover, lipid-metabolism-dependent regulation of CTLA4 and ICOS is also operative in conventional T cells, because naive T cells treated with inhibitors of this pathway or deficient in raptor failed to upregulate these molecules effectively after TCR stimulation (Supplementary Fig. 12 ). We speculate that this constitutes a feedback mechanism, which would account for the immunosuppressive activity of activated non-T reg cells previously described 28, 29 , a notion that awaits further investigation.
Crosstalk between the mTORC1 and mTORC2 signalling pathways has been reported 10 , although the molecular details and functional RESEARCH LETTER significance are unclear. Notably, mTORC2 contributes to Akt activation, which in turn signals to Foxo1 (ref. 26) , and acts in synergy with mTORC1 to negatively control the generation of induced T reg cells 2 . We therefore examined the role of mTORC2 and its interaction with mTORC1 in naturally occurring T reg cells. T reg -specific deletion of Rictor, the defining component of mTORC2, resulted in a small reduction of T reg cells in the periphery (Fig. 4a ). However, loss of Rictor in T reg cells did not perturb T-cell homeostasis, cellularity or cytokine expression at steady state ( Fig. 4b and Supplementary Fig. 13a, b) , or the health status of the mice. Also, Rictor-deficient T reg cells had normal expression of T reg signature molecules, mitochondrial activity and in vitro suppressive activity ( Supplementary Fig. 13c, d) . Thus, in contrast to a crucial requirement of mTORC1 in programming T reg activity, mTORC2 probably contributes to T reg maintenance but is dispensable for T reg function.
To examine the crosstalk between the two mTOR complexes, we analysed mTORC2 activity in raptor-deficient T reg cells. Phosphorylation of well-established mTORC2 targets, Akt Ser 473 and Foxo1/3, was elevated in raptor-deficient T reg cells after anti-CD3/IL-2 ( Fig. 4c ) or anti-CD3/CD28 stimulation ( Supplementary Fig. 14) , consistent with the observation in freshly isolated raptor-deficient T reg cells (Supplementary Fig. 2d ). By contrast, Akt Ser473 phosphorylation was nearly abolished after Rictor deletion ( Fig. 4c and Supplementary Fig. 14a ). Thus, mTORC1 negatively feeds back on mTORC2 in T reg cells. To determine the contribution of mTORC2 activity to Foxp3 cre Rptor fl/fl phenotypes, we generated Foxp3 cre Rptor fl/fl Rictor fl/fl mice. Compared with T cells in Foxp3 cre Rptor fl/fl mice, those in Foxp3 cre Rptor fl/fl Rictor fl/fl mice contained an increased percentage of naive phenotypes (Fig. 4d ) and showed modestly reduced IFN-c production ( Fig. 4e) . Also, the lymphadenopathy phenotype observed in Foxp3 cre Rptor fl/fl mice was ameliorated in Foxp3 cre Rptor fl/fl Rictor fl/fl mice (Fig. 4f) . To test the intrinsic suppressive activity of raptorand Rictor-deficient T reg cells, we generated Cd4 cre Rptor fl/fl Rictor fl/fl mice that eliminated both mTORC1 and mTORC2 activities (Supplementary Fig. 15a, b ). An in vitro suppression assay revealed an intermediate phenotype of raptor/Rictor-deficient T reg cells compared with raptor-deficient and wild-type cells (Fig. 4g ). However, impaired CTLA4 expression and TCR-induced proliferation after raptor deletion were not restored by the concomitant loss of Rictor ( Fig. 4h and Supplementary Fig. 15c ). Furthermore, Foxp3 cre Rptor fl/fl Rictor fl/fl mice still succumbed to an inflammatory disorder, albeit with a small extension of lifespan and less inflammation as compared with Foxp3 cre Rptor fl/fl mice ( Supplementary Fig. 16 ). Therefore, Raptor/mTORC1 signalling promotes T reg function in part through inhibiting mTORC2, although the predominant effect of mTORC1 is to coordinate metabolic programs and T reg suppressive molecules.
Much emphasis has been placed on the transcriptional mechanisms that orchestrate T reg suppressive activity, but how immunological signals are sensed and integrated by T reg cells for their functional activation remains obscure. We show that mTORC1-dependent metabolic programming is a central mechanism to couple immune signals, including TCR and IL-2, and T reg suppressive function. Raptor/mTORC1 promotes the lipogenic program, with the mevalonate pathway particularly important for coordinating T reg proliferation and the optimal induction of effector molecules CTLA4 and ICOS ( Supplementary  Fig. 17 ). Thus, mTORC1-dependent lipid metabolism provides a novel link between two crucial T reg -cell regulators, IL-2 and CTLA4, the loss of which causes fulminant autoimmune diseases 21, 30 . An additional mechanism is through the mTORC1-dependent inhibition of mTORC2, although the modest rescue effect of Rictor deletion in Foxp3 cre Rptor fl/fl mice suggests a relatively minor contribution of this feedback pathway. Notably, mTORC1-dependent metabolic programming operates both under steady state and immune stimulation, and this provides important mechanistic insights into the apparently conflicting observations of the in vitro anergy of T reg cells and their in vivo antigen-primed state [16] [17] [18] . We propose that T reg cells adopt the evolutionarily ancient mTORC1 signalling pathway to link immunological inputs to metabolic activity and functional fitness, therefore implicating mTORC1 as a fundamental rheostat to program T reg -cell suppressive activity through a nonconventional mechanism.
METHODS SUMMARY
The mice used in this study were backcrossed onto the C57BL/6J background. Bone marrow chimaeras were generated by transferring 1 3 10 7 T-cell-depleted bone marrow cells into sub-lethally irradiated (5 Gy) Rag1 -/mice, followed by reconstitution for at least 2 months. T-cell-mediated colitis was induced by intraperitoneal transfer of 4 3 10 5 T eff cells (CD4 1 CD45RB hi CD25 -) from CD45.1 1 mice in the absence or presence of 2 3 10 5 T reg cells into Rag1 -/mice. Lymphocytes were stained with surface antibodies or intracellularly for Foxp3, CTLA4 and caspase 3. Staining for the phosphorylated signalling proteins was carried out with Phosflow kits (BD Biosciences). T reg cells were activated with plate-coated anti-CD3, anti-CD28 and IL-2, in the presence of simvastatin (2 mM; EMD Millipore), 25hydroxycholesterol (0.5 mg ml 21 ; Sigma), or vehicle. The de novo lipogenesis assay was performed by incubating activated T reg cells with 14 C-glucose or 14 C-acetate for 4 h, followed by cell lysis and lipid extraction.
